Trader consensus implies a 74% probability of the CDC issuing a Level 3 Travel Health Notice by December 31, driven by recent elevations to Level 2 for meningococcal disease outbreaks in the Democratic Republic of the Congo's Mangembo Health Zone (March 24) and yellow fever cases across Venezuela (March 16), indicating heightened transmission risks that could warrant escalation if surveillance data shows surges. Persistent global poliovirus circulation in over 30 countries, per the CDC's March 9 update, and ongoing H5N1 avian influenza detections in U.S. wastewater (latest Emerging Infectious Diseases report) further bolster expectations, as historical patterns show CDC frequently advances notices amid multi-country threats. Weekly CDC flu surveillance noting 12 new pediatric deaths last week underscores broader respiratory pressures, though resolutions hinge on international case trajectories and upcoming agency briefings.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · GüncellendiCDC 31 Aralık'a kadar Seviye 3 uyarısı veriyor mu?
CDC 31 Aralık'a kadar Seviye 3 uyarısı veriyor mu?
Evet
$112,107 Hac.
$112,107 Hac.
31 Ara 2026
Evet
$112,107 Hac.
$112,107 Hac.
31 Ara 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus implies a 74% probability of the CDC issuing a Level 3 Travel Health Notice by December 31, driven by recent elevations to Level 2 for meningococcal disease outbreaks in the Democratic Republic of the Congo's Mangembo Health Zone (March 24) and yellow fever cases across Venezuela (March 16), indicating heightened transmission risks that could warrant escalation if surveillance data shows surges. Persistent global poliovirus circulation in over 30 countries, per the CDC's March 9 update, and ongoing H5N1 avian influenza detections in U.S. wastewater (latest Emerging Infectious Diseases report) further bolster expectations, as historical patterns show CDC frequently advances notices amid multi-country threats. Weekly CDC flu surveillance noting 12 new pediatric deaths last week underscores broader respiratory pressures, though resolutions hinge on international case trajectories and upcoming agency briefings.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Piyasa Açıldı: Jan 19, 2026, 3:15 PM ET
Hacim
$112,107Bitiş Tarihi
31 Ara 2026Piyasa Açıldı
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus implies a 74% probability of the CDC issuing a Level 3 Travel Health Notice by December 31, driven by recent elevations to Level 2 for meningococcal disease outbreaks in the Democratic Republic of the Congo's Mangembo Health Zone (March 24) and yellow fever cases across Venezuela (March 16), indicating heightened transmission risks that could warrant escalation if surveillance data shows surges. Persistent global poliovirus circulation in over 30 countries, per the CDC's March 9 update, and ongoing H5N1 avian influenza detections in U.S. wastewater (latest Emerging Infectious Diseases report) further bolster expectations, as historical patterns show CDC frequently advances notices amid multi-country threats. Weekly CDC flu surveillance noting 12 new pediatric deaths last week underscores broader respiratory pressures, though resolutions hinge on international case trajectories and upcoming agency briefings.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Hacim
$112,107Bitiş Tarihi
31 Ara 2026Piyasa Açıldı
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus implies a 74% probability of the CDC issuing a Level 3 Travel Health Notice by December 31, driven by recent elevations to Level 2 for meningococcal disease outbreaks in the Democratic Republic of the Congo's Mangembo Health Zone (March 24) and yellow fever cases across Venezuela (March 16), indicating heightened transmission risks that could warrant escalation if surveillance data shows surges. Persistent global poliovirus circulation in over 30 countries, per the CDC's March 9 update, and ongoing H5N1 avian influenza detections in U.S. wastewater (latest Emerging Infectious Diseases report) further bolster expectations, as historical patterns show CDC frequently advances notices amid multi-country threats. Weekly CDC flu surveillance noting 12 new pediatric deaths last week underscores broader respiratory pressures, though resolutions hinge on international case trajectories and upcoming agency briefings.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · Güncellendi
Harici bağlantılara dikkat edin.
Harici bağlantılara dikkat edin.
Sıkça Sorulan Sorular